Relst Pharma: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Relst Pharma
Largest movements
- Cash +€38,016
up €38,016 (+57.3%), from €66,308 to €104,325
mainly Net result for the year (+€104,934) and Trade debts (+€73,670)
- Receivables within one year +€20,737
up €20,737 (+19.7%), from €105,248 to €125,985
of which Other amounts receivable: +€17,775
- Other debts -€122,997
down €122,997 (-99.6%), from €123,453 to €456
- Reserves +€104,934
up €104,934 (+53.8%), from €195,073 to €300,007
of which Distributable reserves: +€104,934
- Trade debts +€73,670
up €73,670 (+57.1%), from €128,921 to €202,590
- Debts after one year -€12,632
down €12,632 (-35.9%), from €35,222 to €22,591
- Gross operating margin -€25,509
down €25,509 (-13.1%), from €194,246 to €168,737
- Taxes +€19,720
up €19,720 (+127.3%), from €15,491 to €35,211
- Staff costs +€14,660
up €14,660 (+1350.1%), from €1,086 to €15,745
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €668,918 | €714,542 | +€45,624 | +6.8% |
| Fixed assets | 21/28 | €259,636 | €253,349 | -€6,286 | -2.4% |
| Tangible fixed assets | 22/27 | €259,636 | €253,349 | -€6,286 | -2.4% |
| Land and buildings | 22 | €225,000 | €225,000 | = | 0.0% |
| Plant, machinery and equipment | 23 | €34,636 | €26,075 | -€8,560 | -24.7% |
| Furniture and vehicles | 24 | - | €2,274 | +€2,274 | |
| Current assets | 29/58 | €409,283 | €461,192 | +€51,910 | +12.7% |
| Stocks and contracts in progress | 3 | €224,614 | €222,410 | -€2,204 | -1.0% |
| Stocks | 30/36 | €224,614 | €222,410 | -€2,204 | -1.0% |
| Amounts receivable within one year | 40/41 | €105,248 | €125,985 | +€20,737 | +19.7% |
| Trade receivables | 40 | €98,481 | €101,443 | +€2,962 | +3.0% |
| Other amounts receivable | 41 | €6,767 | €24,542 | +€17,775 | +262.7% |
| Cash at bank and in hand | 54/58 | €66,308 | €104,325 | +€38,016 | +57.3% |
| Deferred charges and accrued income | 490/1 | €13,112 | €8,472 | -€4,640 | -35.4% |
| Total equity and liabilities | 10/49 | €668,918 | €714,542 | +€45,624 | +6.8% |
| Equity | 10/15 | €368,408 | €473,342 | +€104,934 | +28.5% |
| Contributions | 10/11 | €6,200 | €6,200 | = | 0.0% |
| Reserves | 13 | €195,073 | €300,007 | +€104,934 | +53.8% |
| Non-distributable reserves | 130/1 | €1,859 | €1,859 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,859 | €1,859 | = | 0.0% |
| Distributable reserves | 133 | €193,214 | €298,148 | +€104,934 | +54.3% |
| Profit (loss) carried forward | 14 | €167,135 | €167,135 | = | 0.0% |
| Amounts payable | 17/49 | €300,510 | €241,200 | -€59,310 | -19.7% |
| Amounts payable after more than one year | 17 | €35,222 | €22,591 | -€12,632 | -35.9% |
| Financial debts | 170/4 | €35,222 | €22,591 | -€12,632 | -35.9% |
| Amounts payable within one year | 42/48 | €265,287 | €218,609 | -€46,679 | -17.6% |
| Current portion of amounts payable after more than one year | 42 | €12,434 | €12,632 | +€198 | +1.6% |
| Trade debts | 44 | €128,921 | €202,590 | +€73,670 | +57.1% |
| Suppliers | 440/4 | €128,921 | €202,590 | +€73,670 | +57.1% |
| Taxes, remuneration and social security | 45 | €480 | €2,930 | +€2,451 | +510.6% |
| Taxes | 450/3 | €480 | €526 | +€46 | +9.5% |
| Remuneration and social security | 454/9 | - | €2,405 | +€2,405 | |
| Other amounts payable | 47/48 | €123,453 | €456 | -€122,997 | -99.6% |
| Remuneration, social security and pensions | 62 | €1,086 | €15,745 | +€14,660 | +1350.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €7,541 | €9,342 | +€1,800 | +23.9% |
| Other operating charges | 640/8 | €3,887 | €3,964 | +€78 | +2.0% |
| Gross operating margin | 9900 | €194,246 | €168,737 | -€25,509 | -13.1% |
| Operating profit (loss) | 9901 | €181,732 | €139,685 | -€42,047 | -23.1% |
| Financial income | 75/76B | €2,397 | €1,454 | -€944 | -39.4% |
| Recurring financial income | 75 | €2,397 | €1,454 | -€944 | -39.4% |
| Financial charges | 65/66B | €1,152 | €994 | -€158 | -13.7% |
| Recurring financial charges | 65 | €1,152 | €994 | -€158 | -13.7% |
| Profit (loss) for the period before taxes | 9903 | €182,977 | €140,145 | -€42,833 | -23.4% |
| Income taxes | 67/77 | €15,491 | €35,211 | +€19,720 | +127.3% |
| Profit (loss) for the period | 9904 | €167,487 | €104,934 | -€62,553 | -37.3% |
| Profit (loss) for the period to be appropriated | 9905 | €167,487 | €104,934 | -€62,553 | -37.3% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 6 October 2026 via checked.be.